Compare Novo Nordisk A/S (NVO) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Ulta Beauty Inc — how do they compare? Novo Nordisk A/S trades at $38.63 (market cap $165.31B), while Ulta Beauty Inc trades at $570.37 (market cap $24.12B). The key difference: Novo Nordisk A/S is far larger — about 6.9× Ulta Beauty Inc's market cap, and Novo Nordisk A/S pays a 4.71% dividend while Ulta Beauty Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novo Nordisk A/S for 116 Days and Ulta Beauty Inc for 92 Days on average.
| NVO | ULTA | |
|---|---|---|
Market Cap | $165.31B | $24.12B |
Volume | 11,432,838 | 457,598 |
Sector | Health | Consumer Cyclical |
52-Week High | $63.98 | $706.82 |
52-Week Low | $35.29 | $450.75 |
Typical Hold Time | 116 Days | 92 Days |
Enterprise Value | $179.56B | $26.43B |
Dividend Yield | 4.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $38.41, up 0.38% with strong fundamentals including 35.35% net margin and consistent earnings beats. The stock shows bearish technical signals but maintains robust profitability with $102.43B net income. Recent news highlights pipeline developments including Wegovy pill data and FDA reviews, while competition with Eli Lilly intensifies in the obesity drug market.
NVO presents a compelling value opportunity with a 9.66 P/E ratio and 59% upside to the $44.67 consensus target. However, technical weakness and competitive pressures from Lilly's new drug candidates pose near-term risks. The company's strong cash flow generation and 59.82% ROE support long-term growth prospects despite regulatory uncertainties.
ULTA Beauty trades at $570.02, up 4.5% today, showing strong momentum with a bullish technical setup and positive analyst sentiment. The company delivered Q2 2026 earnings beat ($6.55 actual vs. $6.22 expected) and raised 2026 guidance, supported by robust e-commerce growth. Valuation metrics show a P/E of 20.55 and P/S of 1.92, while profitability remains solid with 39.3% gross margins and 46.1% ROE. Recent news highlights expansion into wellness categories and omnichannel strength.
Outlook remains positive with consensus price target of $624.93 (9.6% upside), though margin pressure and flat store traffic pose execution risks. The stock's current price near resistance at $572 suggests potential near-term consolidation before further gains. Institutional ownership trends show mixed activity with recent CEO share sales offset by pension fund accumulation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
